In a significant step towards strengthening public health safety in Uttar Pradesh, appointment letters were distributed on Sunday by the Chief Minister to 357 selected candidates for the post of Junior Analyst (Drugs) under the Food Safety and Drug Administration Department.

The recruitment process, conducted against the 2024 advertisement and completed in 2026, was carried out transparently through the Uttar Pradesh Subordinate Services Selection Commission. These appointments will accelerate the pace of drug quality testing.

At the same time, all 18 laboratories in the state will become fully operational, and annual analysis capacity will increase by more than four times.

The appointment of Junior Analysts (Drugs) will provide fresh momentum to the system of quality testing for medicines and cosmetic products in the state.

Their primary responsibility will be to scientifically test samples collected by drug inspectors from various districts under the Drugs and Cosmetics Act, 1940 and related rules. These tests will not only ensure the purity, efficacy, and compliance of medicines with prescribed standards, but will also help identify counterfeit, adulterated, and substandard products, paving the way for swift action against them.

This will establish strict monitoring over the quality of medicines and cosmetic products available in the market, ensuring safe and trustworthy products for the public.

Moreover, testing in accordance with national and international standards will further strengthen the state’s quality control system, making it a crucial step towards safeguarding public health.

To strengthen the drug quality testing system in the state, modern drug laboratories have now been established at every divisional headquarters, taking the total number of laboratories to 18, all equipped with furniture and advanced equipment.

Earlier, the entire state’s testing system depended on only five laboratories, limiting its reach and efficiency.

Following the appointment of Junior Analysts, all these laboratories will function at full capacity, ensuring faster sample testing and a significant reduction in pending cases.

This will not only ensure timely testing but also make quality control monitoring more effective and extensive.

The strengthened system will enhance the credibility of medicines and cosmetic products in the state while providing a robust foundation for public health safety.

With these new appointments, the state’s capacity for testing drug samples will witness a historic increase.

Until now, only around 12,000 samples could be tested annually, but this capacity will now rise to 54,500 samples per year, marking an increase of more than four times. This will not only speed up the testing process but also ensure broader monitoring of the quality of medicines and cosmetic products.

The enhanced capacity will enable timely examination of samples, allowing quicker control over substandard or suspicious products available in the market.